Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure

Timmis, 2018, European Society of Cardiology: Cardiovascular Disease Statistics 2017, Eur. Heart J., 39, 508, 10.1093/eurheartj/ehx628

Moses, 2003, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N. Engl. J. Med., 349, 1315, 10.1056/NEJMoa035071

Waksman, 2014, Correlates and outcomes of late and very late drug-eluting stent thrombosis: Results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis), JACC Cardiovasc. Interv., 7, 1093, 10.1016/j.jcin.2014.04.017

Claessen, 2014, Stent thrombosis: A clinical perspective, JACC Cardiovasc. Interv., 7, 1081, 10.1016/j.jcin.2014.05.016

Torrado, 2018, Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis, J. Am. Coll. Cardiol., 71, 1676, 10.1016/j.jacc.2018.02.023

Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126

Claessen, 2018, The quest for the optimal treatment for in-stent restenosis, Catheter. Cardiovasc. Interv., 92, 300, 10.1002/ccd.27777

Magalhaes, 2014, Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations, Circ. Cardiovasc. Interv., 7, 768, 10.1161/CIRCINTERVENTIONS.114.001341

Gori, 2019, Predictors of stent thrombosis and their implications for clinical practice, Nat. Rev. Cardiol., 16, 243, 10.1038/s41569-018-0118-5

Kawamoto, 2004, Relation of C-reactive protein to restenosis after coronary stent implantation and to restenosis after coronary atherectomy, Am. J. Cardiol., 94, 104, 10.1016/j.amjcard.2004.03.037

Yilmaz, 2015, Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis, Scand. Cardiovasc. J., 49, 39, 10.3109/14017431.2014.989537

Liu, 2013, Plasma levels of interleukin 18, interleukin 10, and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous coronary intervention, Inflammation, 36, 1129, 10.1007/s10753-013-9647-6

Ullrich, 2020, Coronary Stent Thrombosis- Predictors and Prevention, Dtsch. Arztebl. Int., 117, 320

Tada, 2013, Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients, JACC Cardiovasc. Interv., 6, 1267, 10.1016/j.jcin.2013.06.015

Palmerini, 2013, Stent thrombosis with drug-eluting stents: Is the paradigm shifting?, J. Am. Coll. Cardiol., 62, 1915, 10.1016/j.jacc.2013.08.725

Sakamoto, A., Jinnouchi, H., Torii, S., Virmani, R., and Finn, A.V. (2018). Understanding the Impact of Stent and Scaffold Material and Strut Design on Coronary Artery Thrombosis from the Basic and Clinical Points of View. Bioengineering, 5.

Vorpahl, 2010, Pathobiology of stent thrombosis after drug-eluting stent implantation, Curr. Pharm. Des., 16, 4064, 10.2174/138161210794454879

Finn, 2007, Vascular responses to drug eluting stents: Importance of delayed healing, Arterioscler. Thromb. Vasc. Biol., 27, 1500, 10.1161/ATVBAHA.107.144220

Nakazawa, 2011, Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents, J. Am. Coll. Cardiol., 57, 390, 10.1016/j.jacc.2010.05.066

Borovac, 2019, Neoatherosclerosis after drug-eluting stent implantation: A novel clinical and therapeutic challenge, Eur. Heart J. Cardiovasc. Pharmacother., 5, 105, 10.1093/ehjcvp/pvy036

McFadden, 2018, Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document, Circulation, 137, 2635, 10.1161/CIRCULATIONAHA.117.029289

Hiebl, 2017, Effects of Tacrolimus or Sirolimus on the adhesion of vascular wall cells: Controlled in-vitro comparison study, Clin. Hemorheol. Microcirc., 67, 309, 10.3233/CH-179211

Mori, 2017, Revisiting the role of durable polymers in cardiovascular devices, Expert Rev. Cardiovasc. Ther., 15, 835, 10.1080/14779072.2017.1386098

Szott, 2016, Blood compatibility assessment of polymers used in drug eluting stent coatings, Biointerphases, 11, 029806, 10.1116/1.4944586

Torii, 2019, Acute thrombogenicity of fluoropolymer-coated versus biodegradable and polymer-free stents, EuroIntervention, 14, 1685, 10.4244/EIJ-D-17-00728

Bangalore, 2018, Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease, Circulation, 138, 2216, 10.1161/CIRCULATIONAHA.118.034456

Iantorno, 2018, Meta-Analysis of the Impact of Strut Thickness on Outcomes in Patients With Drug-Eluting Stents in a Coronary Artery, Am. J. Cardiol., 122, 1652, 10.1016/j.amjcard.2018.07.040

Taniguchi, 2015, Two-year vessel healing after everolimus-eluting stent implantation: Serial assessment by optical coherence tomography, J. Cardiol., 65, 298, 10.1016/j.jjcc.2014.07.003

Kawakami, 2018, Initial pathological responses of second-generation everolimus-eluting stents implantation in Japanese coronary arteries: Comparison with first-generation sirolimus-eluting stents, J. Cardiol., 71, 452, 10.1016/j.jjcc.2017.11.009

Picard, 2019, Comparison of the biodegradable polymer everolimus-eluting stent with contemporary drug-eluting stents: A systematic review and meta-analysis, Int. J. Cardiol., 278, 51, 10.1016/j.ijcard.2018.11.113

Anadol, 2017, The mechanisms of late scaffold thrombosis, Clin. Hemorheol. Microcirc., 67, 343, 10.3233/CH-179214

Kereiakes, 2016, Bioresorbable Vascular Scaffolds for Coronary Revascularization, Circulation, 134, 168, 10.1161/CIRCULATIONAHA.116.021539

Chen, 2006, Bare metal stent restenosis is not a benign clinical entity, Am. Heart J., 151, 1260, 10.1016/j.ahj.2005.08.011

Schnorbus, 2020, Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: A randomized, blinded, parallel study, Eur. Heart J., 41, 3144, 10.1093/eurheartj/ehz917

Gori, T. (2018). Endothelial Function: A Short Guide for the Interventional Cardiologist. Int. J. Mol. Sci., 19.

Donners, 2003, Inflammation and restenosis: Implications for therapy, Ann. Med., 35, 523, 10.1080/07853890310014876

Christen, 2001, Mechanisms of neointima formation and remodeling in the porcine coronary artery, Circulation, 103, 882, 10.1161/01.CIR.103.6.882

Puricel, 2016, Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT), Int. J. Cardiol., 202, 525, 10.1016/j.ijcard.2015.09.085

Togni, 2007, Local vascular dysfunction after coronary paclitaxel-eluting stent implantation, Int. J. Cardiol., 120, 212, 10.1016/j.ijcard.2006.09.021

Inoue, 2011, Vascular inflammation and repair: Implications for re-endothelialization, restenosis, and stent thrombosis, JACC Cardiovasc. Interv., 4, 1057, 10.1016/j.jcin.2011.05.025

Moldoveanu, 2008, Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: Lipoprotein associated phospholipase A2, and myeloperoxidase, Clin. Biochem., 41, 1429, 10.1016/j.clinbiochem.2008.09.109

Liu, J., Li, M., Lu, H., Qiao, W., Xi, D., Luo, T., Xiong, H., and Guo, Z. (2015). Effects of probucol on restenosis after percutaneous coronary intervention: A systematic review and meta-analysis. PLoS ONE, 10.

Kufner, 2016, Randomized Trial of Polymer-Free Sirolimus- and Probucol-Eluting Stents Versus Durable Polymer Zotarolimus-Eluting Stents: 5-Year Results of the ISAR-TEST-5 Trial, JACC Cardiovasc. Interv., 9, 784, 10.1016/j.jcin.2016.01.009

Guerra, 2014, Pharmacological inhibition of coronary restenosis: Systemic and local approaches, Expert Opin. Pharmacother., 15, 2155, 10.1517/14656566.2014.948844

Ullrich, 2019, The pleiotropic effects of antiplatelet therapies, Clin. Hemorheol. Microcirc., 73, 29, 10.3233/CH-199214

Cook, 2009, Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis, Circulation, 120, 391, 10.1161/CIRCULATIONAHA.109.854398

Nebeker, 2006, Hypersensitivity cases associated with drug-eluting coronary stents: A review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project, J. Am. Coll. Cardiol., 47, 175, 10.1016/j.jacc.2005.07.071

Virmani, 2004, Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?, Circulation, 109, 701, 10.1161/01.CIR.0000116202.41966.D4

Chaabane, 2013, Biological responses in stented arteries, Cardiovasc. Res., 99, 353, 10.1093/cvr/cvt115

Koster, 2000, Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis, Lancet, 356, 1895, 10.1016/S0140-6736(00)03262-1

Hiebl, 2015, Biocompatibility of a novel zinc stent with a closed-cell-design, Clin. Hemorheol. Microcirc., 61, 205, 10.3233/CH-151983

Jinnouchi, H., Kutyna, M., Torii, S., Cheng, Q., Sakamoto, A., Guo, L., Cornelissen, A., Perkins, L.E.L., Hossainy, S.F., and Pacetti, S.D. (2020). Comparison of Acute Thrombogenicity and Albumin Adsorption in Three Different Durable Polymer Coronary Drug-Eluting Stents. EuroIntervention.

Mori, 2020, Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model, J. Interv. Cardiol., 2020, 1956015, 10.1155/2020/1956015

Riegger, 2016, Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: A report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium, Eur. Heart J., 37, 1538, 10.1093/eurheartj/ehv419

Taniwaki, 2016, Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography, Circulation, 133, 650, 10.1161/CIRCULATIONAHA.115.019071

Polimeni, 2020, Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents, Cardiol. Clin., 38, 639, 10.1016/j.ccl.2020.07.008

Katagiri, 2018, A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): A randomised, single-blind, multicentre, non-inferiority, phase 3 trial, Lancet, 391, 431, 10.1016/S0140-6736(17)33103-3

Cassese, 2018, Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: A meta-analysis of randomised trials, EuroIntervention, 14, 224, 10.4244/EIJ-D-18-00024

Bangalore, 2017, Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents, JACC Cardiovasc. Interv., 10, 462, 10.1016/j.jcin.2016.12.002

Yamaji, 2018, Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization, Circ. Cardiovasc. Interv., 11, e006741, 10.1161/CIRCINTERVENTIONS.118.006741

Zhu, P., Zhou, X., Zhang, C., Li, H., Zhang, Z., and Song, Z. (2018). Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: A meta-analysis of randomized trials. BMC Cardiovasc. Disord., 18.

Jeger, 2013, Stent thrombosis after coronary stent implantation: A protective effect of high-dose statin therapy?, Cardiology, 126, 115, 10.1159/000350822

Jeong, 2013, Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein, Int. J. Cardiol., 167, 1848, 10.1016/j.ijcard.2012.04.123

Nakamura, 2019, Different Neoatherosclerosis Patterns in Drug-Eluting-and Bare-Metal Stent Restenosis—Optical Coherence Tomography Study, Circ. J., 83, 313, 10.1253/circj.CJ-18-0701

Ando, 2013, Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: Integrated backscatter intravascular ultrasound analysis for in-stent restenosis, Eur. Heart J. Cardiovasc. Imaging, 14, 996, 10.1093/ehjci/jet003

Jinnouchi, 2017, Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation- An Optical Coherence Tomography Study, Circ. J., 81, 450, 10.1253/circj.CJ-16-1069

Joner, 2008, Endothelial cell recovery between comparator polymer-based drug-eluting stents, J. Am. Coll. Cardiol., 52, 333, 10.1016/j.jacc.2008.04.030

Yahagi, 2016, Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis, Nat. Rev. Cardiol., 13, 79, 10.1038/nrcardio.2015.164

Otsuka, 2015, Neoatherosclerosis: Overview of histopathologic findings and implications for intravascular imaging assessment, Eur. Heart J., 36, 2147, 10.1093/eurheartj/ehv205

Parry, 2005, Drug-eluting stents: Sirolimus and paclitaxel differentially affect cultured cells and injured arteries, Eur. J. Pharmacol., 524, 19, 10.1016/j.ejphar.2005.09.042

Saxton, 2017, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 169, 361, 10.1016/j.cell.2017.03.035

Jinnouchi, 2020, Advances in mammalian target of rapamycin kinase inhibitors: Application to devices used in the treatment of coronary artery disease, Future Med. Chem., 12, 1181, 10.4155/fmc-2019-0304

Harari, 2018, Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents-Brief Report, Arterioscler. Thromb. Vasc. Biol., 38, 2217, 10.1161/ATVBAHA.118.311321

Jang, 2015, Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: Qualitative optical coherence tomographic analysis, Atherosclerosis, 242, 553, 10.1016/j.atherosclerosis.2015.08.014

Cui, 2016, Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms, Oxid. Med. Cell. Longev., 2016, 5924234, 10.1155/2016/5924234